Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;288(13):4053-4063.
doi: 10.1111/febs.15686. Epub 2021 Jan 9.

Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for 19 F-NMR studies in solution

Affiliations
Free article

Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for 19 F-NMR studies in solution

Huixia Wang et al. FEBS J. 2021 Jul.
Free article

Abstract

The human glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are class B G protein-coupled receptors (GPCRs) that are activated by interactions with, respectively, the glucagon-like peptide-1 (GLP-1) and glucagon (GCG). These polypeptide hormones are involved in the regulation of lipid and cholic acid metabolism, and thus play an important role in the pathogenesis of glucose metabolism and diabetes mellitus, which attracts keen interest of these GPCRs as drug targets. GLP-1R and GCGR have therefore been extensively investigated by X-ray crystallography and cryo-electron microscopy (cryo-EM), so that their structures are well known. Here, we present the groundwork for using nuclear magnetic resonance (NMR) spectroscopy in solution to complement the molecular architectures with information on intramolecular dynamics and on the thermodynamics and kinetics of interactions with physiological ligands and extrinsic drug candidates. This includes the generation of novel, near-wild-type constructs of GLP-1R and GCGR, optimization of the solution conditions for NMR studies in detergent micelles and in nanodiscs, post-translational chemical introduction of fluorine-19 NMR probes, and sequence-specific assignments of the 19 F-labels attached to indigenous cysteines. Addition of the negative allosteric modulator (NAM) NNC0640 was critically important for obtaining the long-time stability needed for our NMR experiments, and we report on novel insights into the allosteric effects arising from binding of NNC0640 to the transmembrane domain of GLP-1R (GLP-1R[TMD]).

Keywords: 19F-NMR; GPCR; glucagon receptor; glucagon-like peptide-1 receptor; negative allosteric modulator.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Baggio LL & Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157.
    1. Rodgers RL (2012) Glucagon and cyclic AMP: time to turn the page? Curr Diabetes Rev 8, 362-381.
    1. Müller TD, Finan B, Clemmensen C, DiMarchi RD & Tschöp MH (2017) The new biology and pharmacology of glucagon. Physiol Rev 97, 721-766.
    1. Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ & Husain M (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117, 2340-2350.
    1. Drucker DJ (1990) Glucagon and the glucagon-like peptides. Pancreas 5, 484-488.

Publication types

MeSH terms

LinkOut - more resources